163 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
101 | 22614869 | Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance. | 2012 Aug | 3 |
102 | 22701315 | Reversing multidrug resistance in breast cancer cells by silencing ABC transporter genes with nanoparticle-facilitated delivery of target siRNAs. | 2012 | 1 |
103 | 22989452 | [Effect of Src tyrosine kinase inhibition on the drug-resistance as well as MDR1 and LRP expression of the human cis-platinum-resistant lung cancer cell line A549/DDP]. | 2012 Sep | 2 |
104 | 23038675 | Possible involvement of glycolipids in anticancer drug resistance of human ovarian serous carcinoma-derived cells. | 2012 Dec | 1 |
105 | 23152886 | Quercetin suppresses drug-resistant spheres via the p38 MAPK-Hsp27 apoptotic pathway in oral cancer cells. | 2012 | 1 |
106 | 20627363 | Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine. | 2011 Feb | 2 |
107 | 20856196 | Human AP endonuclease (APE1/Ref-1) and its acetylation regulate YB-1-p300 recruitment and RNA polymerase II loading in the drug-induced activation of multidrug resistance gene MDR1. | 2011 Jan 27 | 1 |
108 | 21325069 | Identification of loss of p16 expression and upregulation of MDR-1 as genetic events resulting from two novel chromosomal translocations found in a plasmablastic lymphoma of the uterus. | 2011 Apr 15 | 1 |
109 | 21332314 | Impact of ABCB1 C3435T polymorphism on lymph node regression in multimodality treatment of locally advanced esophageal cancer. | 2011 Feb | 1 |
110 | 21805041 | Expression of P-gp, MRP, LRP, GST-π and TopoIIα and intrinsic resistance in human lung cancer cell lines. | 2011 Nov | 1 |
111 | 19875192 | Association of expression of MRP1, BCRP, LRP and ERCC1 with outcome of patients with locally advanced non-small cell lung cancer who received neoadjuvant chemotherapy. | 2010 Jul | 1 |
112 | 20168208 | Reduced drug accumulation is more important in acquired resistance against oxaliplatin than against cisplatin in isogenic colon cancer cells. | 2010 Jun | 1 |
113 | 20189873 | Association of MDR1 and ERCC1 polymorphisms with response and toxicity to cisplatin-based chemotherapy in non-small-cell lung cancer patients. | 2010 Mar | 1 |
114 | 20458768 | Establishment of a human hepatoma multidrug resistant cell line in vitro. | 2010 May 14 | 1 |
115 | 20628484 | Association of ABCC2 and CDDP-Resistance in Two Sublines Resistant to CDDP Derived from a Human Nasopharyngeal Carcinoma Cell Line. | 2010 | 2 |
116 | 20689757 | MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotherapy. | 2010 Aug | 2 |
117 | 20944142 | Down-regulation of P-glycoprotein is associated with resistance to cisplatin and VP-16 in human lung cancer cell lines. | 2010 Sep | 4 |
118 | 18812689 | MDR1 single nucleotide polymorphism G2677T/A and haplotype are correlated with response to docetaxel-cisplatin chemotherapy in patients with non-small-cell lung cancer. | 2009 | 2 |
119 | 19733628 | Increase in morphine antinociceptive activity by a P-glycoprotein inhibitor in cisplatin-induced neuropathy. | 2009 Nov 6 | 2 |
120 | 19900859 | Expression of MRP1, BCRP, LRP, and ERCC1 in advanced non-small-cell lung cancer: correlation with response to chemotherapy and survival. | 2009 Nov | 1 |
121 | 18809583 | Regulatory role of human AP-endonuclease (APE1/Ref-1) in YB-1-mediated activation of the multidrug resistance gene MDR1. | 2008 Dec | 1 |
122 | 19000447 | [Correlation of expression of P-glycoprotein and inhibitor of apoptosis proteins to chemosensitivity in gastrointestinal carcinoma tissues]. | 2008 Nov | 2 |
123 | 17190787 | Characteristic expression of Lewis-antigenic glycolipids in human ovarian carcinoma-derived cells with anticancer drug-resistance. | 2007 Mar | 1 |
124 | 17374987 | Using attenuated Salmonella typhi as tumor targeting vector for MDR1 siRNA delivery. | 2007 Apr | 2 |
125 | 17611393 | Bridge linkage role played by CD98hc of anti-tumor drug resistance and cancer metastasis on cisplatin-resistant ovarian cancer cells. | 2007 Jun | 1 |
126 | 18231753 | MDR1 and MDR3 genes and drug resistance to cisplatin of ovarian cancer cells. | 2007 Dec | 1 |
127 | 16478794 | MDR1 polymorphisms predict the response to etoposide-cisplatin combination chemotherapy in small cell lung cancer. | 2006 Mar | 2 |
128 | 16995873 | Characteristic expression of globotriaosyl ceramide in human ovarian carcinoma-derived cells with anticancer drug resistance. | 2006 Dec | 1 |
129 | 15643508 | Bcl-2 overexpression enhances in vitro sensitivity against docetaxel in non-small cell lung cancer. | 2005 Feb | 2 |
130 | 15650019 | The pregnane X receptor regulates gene expression in a ligand- and promoter-selective fashion. | 2005 May | 2 |
131 | 16026610 | Cancer cell adaptation to chemotherapy. | 2005 Jul 18 | 3 |
132 | 14726695 | Overexpression of ZNRD1 promotes multidrug-resistant phenotype of gastric cancer cells through upregulation of P-glycoprotein. | 2004 Apr | 1 |
133 | 15262121 | The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model. | 2004 Jul | 3 |
134 | 15517878 | Cyclooxygenase-2 gene induction causes CDDP resistance in colon cancer cell line, HCT-15. | 2004 Sep-Oct | 2 |
135 | 16107775 | MDR1, MRP1 and MRP2 genotypes and in vitro chemosensitivity in Japanese patients with colorectal adenocarcinomas. | 2004 | 3 |
136 | 12528803 | Cisplatin, doxorubicin and paclitaxel induce mdr1 gene transcription in ovarian cancer cell lines. | 2003 | 1 |
137 | 14671431 | The farnesyl protein transferase inhibitor lonafarnib (SCH66336) is an inhibitor of multidrug resistance proteins 1 and 2. | 2003 Dec | 1 |
138 | 12142085 | The gain of function of the p53 mutant Asp281Gly is dependent on its ability to form tetramers. | 2002 Nov 8 | 1 |
139 | 12365029 | The role of the MDR1 gene in the development of multidrug resistance in human hepatoblastoma: clinical course and in vivo model. | 2002 Oct 15 | 1 |
140 | 12370750 | Reversal of drug resistance using hammerhead ribozymes against multidrug resistance-associated protein and multidrug resistance 1 gene. | 2002 Nov | 1 |
141 | 12403069 | MDR1 up-regulated by apoptotic stimuli suppresses apoptotic signaling. | 2002 Sep | 3 |
142 | 11500053 | Reversal of cisplatin and multidrug resistance by ribozyme-mediated glutathione suppression. | 2001 Aug 17 | 1 |
143 | 11745426 | Induction of MRP5 and SMRP mRNA by adriamycin exposure and its overexpression in human lung cancer cells resistant to adriamycin. | 2001 Nov 1 | 2 |
144 | 14994074 | [Establishment and biological characteristics of cisplatin resistant cell line from human tongue squamous cell carcinoma Tca8113]. | 2001 Mar | 1 |
145 | 10601617 | Clofazimine and B4121 sensitize an intrinsically resistant human colon cancer cell line to P-glycoprotein substrates. | 2000 Jan-Feb | 2 |
146 | 10764626 | Low-level doxorubicin resistance in benzo[a]pyrene-treated KB-3-1 cells is associated with increased LRP expression and altered subcellular drug distribution. | 2000 Apr 15 | 1 |
147 | 10433011 | Interferon-alpha modulates resistance to cisplatin in three human hepatoma cell lines. | 1999 Jun | 2 |
148 | 11817335 | The role of P-glycoprotein in human gastric cancer xenografts in response to chemotherapy. | 1999 | 1 |
149 | 9815817 | Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents. | 1997 Aug | 1 |
150 | 8599869 | Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells. | 1996 | 1 |